160 related articles for article (PubMed ID: 18076370)
1. Targeting synuclein-gamma to counteract drug resistance in cancer.
Singh VK; Jia Z
Expert Opin Ther Targets; 2008 Jan; 12(1):59-68. PubMed ID: 18076370
[TBL] [Abstract][Full Text] [Related]
2. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs.
Singh VK; Zhou Y; Marsh JA; Uversky VN; Forman-Kay JD; Liu J; Jia Z
Cancer Res; 2007 Jan; 67(2):626-33. PubMed ID: 17234772
[TBL] [Abstract][Full Text] [Related]
3. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.
Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J
Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929
[TBL] [Abstract][Full Text] [Related]
4. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
[TBL] [Abstract][Full Text] [Related]
5. Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.
Strohl A; Mori K; Akers S; Bshara W; Buttin B; Frederick PJ; Helenowski IB; Morrison CD; Odunsi K; Schink JC; Scholtens DM; Wei JJ; Kim JJ
J Ovarian Res; 2016 Nov; 9(1):75. PubMed ID: 27809878
[TBL] [Abstract][Full Text] [Related]
6. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
7. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.
Inaba S; Li C; Shi YE; Song DQ; Jiang JD; Liu J
Breast Cancer Res Treat; 2005 Nov; 94(1):25-35. PubMed ID: 16142440
[TBL] [Abstract][Full Text] [Related]
8. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose.
Fei J; Xiao C; Yang M; Zhou X; Gong P
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313952
[TBL] [Abstract][Full Text] [Related]
10. Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
Morgan J; Hoekstra AV; Chapman-Davis E; Hardt JL; Kim JJ; Buttin BM
Gynecol Oncol; 2009 Aug; 114(2):293-8. PubMed ID: 19476987
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
Zhou Y; Inaba S; Liu J
Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
[TBL] [Abstract][Full Text] [Related]
12. [Overexpression of synuclein-gamma confers resistance to antimicrotubule drugs against human hepatoma cells].
Cheng SX; Zhang S; Zhang H; Song DQ; Wang YP; Li YH; You XF; Wang YM; Jiang JD
Yao Xue Xue Bao; 2010 Jun; 45(6):724-9. PubMed ID: 20939180
[TBL] [Abstract][Full Text] [Related]
13. Insight into residues involved in the structure and function of the breast cancer associated protein human gamma synuclein.
Manivel P; Muthukumaran J; Kannan M; Krishna R
J Mol Model; 2011 Feb; 17(2):251-63. PubMed ID: 20437261
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
[TBL] [Abstract][Full Text] [Related]
15. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Winder AD; Maniar KP; Wei JJ; Liu D; Scholtens DM; Lurain JR; Schink JC; Buttin BM; Filiaci VL; Lankes HA; Ramirez NC; Park K; Singh M; Lieberman RW; Mannel RS; Powell MA; Backes FJ; Mathews CA; Pearl ML; Secord AA; Peace DJ; Mutch DG; Creasman WT; Kim JJ
Cancer; 2017 Apr; 123(7):1144-1155. PubMed ID: 27926776
[TBL] [Abstract][Full Text] [Related]
16. [The correlation of synuclein-γ and matrix metalloproteinase 9 in breast cancer].
Chen J; Huang S; Wu KJ; Wang YK; Jia YJ; Lu YS; Weng ZY
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):641-4. PubMed ID: 24256593
[TBL] [Abstract][Full Text] [Related]
17. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
Liu C; Qu L; Zhao C; Shou C
J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
[TBL] [Abstract][Full Text] [Related]
18. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Syriac S; Godoy H; Dupont N; Liu S; Odunsi K
Gynecol Oncol; 2012 Jan; 124(1):148-52. PubMed ID: 22015044
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J
Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845
[TBL] [Abstract][Full Text] [Related]
20. Stage-specific expression of breast cancer-specific gene gamma-synuclein.
Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
